Clinical Trial Update: Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tranilast as a radiosensitizer for re-irradiation in recurrent nasopharyngeal carcinoma is ongoing, with status currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Tranilast (tranilast)

Snippet

Sponsor: Jian Guan | Conditions: Nasopharyngeal Carcinoma, Recurrent Cancer | Phase 2 | Status: UNKNOWN